Loading…
← CockpitCompetitor Analysis › IOLCP.NS IOL Chemicals & Pharmaceuticals Ltd.Open in the cockpit ↗

IOL Chemicals & Pharmaceuticals Ltd.IOLCP.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Specialty
Momentum leader 94
Mkt cap
$596M
US dollars, full cap
Free float
28%
of shares outstanding
$/day
$7.01M
20-day average traded
Fwd P/E
22.3×
forward earnings
ROIC−WACC
-3.7 pp
WACC 14.2%
Hurdle
+24 pp
Req g minus delivered
Next earnings
83 days
9 Feb 2027
Close · INR₹189.74
1D-0.5%
1W-9.0%
1M+3.6%
3M+19.2%
6M+72.3%
YTD+130.7%
1Y+92.6%
ATR %5.6%
Beta0.98
52w lowhigh15.3% off high

What IOL Chemicals & Pharmaceuticals does

Employees: 3,592

IOL Chemicals & Pharmaceuticals at a glance

Size IOL Chemicals & Pharmaceuticals (IOLCP.NS) is an India Materials company (Chemicals: Specialty) with a market value of $596M, the 786th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹189.74 on 18 Nov 2026.

Performance Over six months the shares gained 72.3%, against -30.4% for the median peer and +3.8% for the India market (cap-weighted) — 2nd highest of 20 in its peer set.

Growth Revenue grew 26.8% over the last twelve months (peer median +19.5%); the operating margin is 10.1% (peer median 8.1%).

Valuation It trades at 22.3× forward earnings against a peer median of 11.6× (5th most expensive of 12).

Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +24 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 3.7 points below its cost of capital (14.2% WACC).

Next results Next results expected around 9 Feb 2027 (exchange calendar; dates can move).

Relative performance

10015021 May 202621 Aug 202618 Nov 2026IOLCP.NS 159Peer median 70
Six months, rebased to 100: IOL Chemicals & Pharmaceuticals against the median of its 20 peers (local-currency closes).

IOL Chemicals & Pharmaceuticals financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹27.5B₹23.1B₹20.7B₹21.2B₹22.1B
Revenue growth—+12%-2%-4%—
Gross profit₹6.66B₹2.89B₹2.34B₹2.70B₹2.75B
EBITDA₹3.63B₹2.63B₹1.96B₹2.23B₹2.20B
Net income₹2.03B₹1.38B₹1.01B₹1.34B₹1.39B
Free cash flown/a₹384M-₹374M₹130M-₹882M
Capital expendituren/a₹1.73B₹2.14B₹2.74B₹2.12B
Total debt₹2.01B₹1.35B₹1.17B₹328M₹798M

Quarterly statements and history in the cockpit →

IOL Chemicals & Pharmaceuticals competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+100%-25%0%+25%68838630047824656032123013956038220040004116497130124630155744611709121600603790LCFSIOLCP.NS6-month return →1-month return →
Up and to the right = strong over both horizons. IOL Chemicals & Pharmaceuticals is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%0×50×100×150×68838624656032126038220040004971300848121600688733LCFSIOLCP.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. IOL Chemicals & Pharmaceuticals is the large dot.

Capital: growth delivered against growth the price implies

0%+50%+100%0%50%100%3004786038220040004116497144611709121600LCFSIOLCP.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. IOL Chemicals & Pharmaceuticals is the large dot.

IOL Chemicals & Pharmaceuticals competitors and peer comparison

How IOL Chemicals & Pharmaceuticals compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

IOL Chemicals & Pharmaceuticals against its 20 peers (data as of 18 Nov 2026)
MeasureIOLCP.NSPeer medianRank in peer set
1-month return+3.6%-11.1%5th highest of 21
6-month return+72.3%-30.4%2nd highest of 20
Distance from 52-week high-15.3%-52.8%4th highest of 21
Revenue growth (TTM)+26.8%+19.5%9th highest of 21
Operating margin10.1%8.1%10th highest of 20
Forward P/E22.3×11.6×5th most expensive of 12
Growth the price implies (Req g, 7 yrs)27.1%7.2%4th most demanding of 12
Growth delivered (Del g)+3.5%+6.9%5th lowest of 11
Hurdle (Req g minus delivered)+23.7 pp+2.1 pp2nd most demanding of 11
ROIC minus cost of capital-3.7 pp-0.7 pp7th lowest of 20
EV / EBITDA15.5×6.2×2nd most expensive of 7
Net debt / EBITDA0.2×-0.7×2nd most indebted of 7

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
IOL Chemicals & Pharmaceuticals IOLCP.NSIndia$596M+72%+27%10%22.3×27.1%+3.5%
Pan Asian Microvent Tech (Jiangsu) 688386.SSChina$598M-50%+12%15%36.6×n/an/a
Hangzhou Gaoxin Materials Technology 300478.SZChina$600M-21%-21%-9%n/a29.9%-0.9%
Jiangsu Lopal Tech 2465.HKHong Kong$590M-61%+107%7%4.8×n/an/a
Cybrid Technologies 603212.SSChina$588M-40%-9%-7%162.9×n/an/a
Jiangsu Baichuan High-Tech New Materials 002455.SZChina$604M-43%+9%1%n/an/an/a
Renxin New Material 301395.SZChina$587M+13%+1%-6%n/an/an/a
Zhejiang Jiaao Enprotech Stock 603822.SSChina$585M-27%+101%19%7.9×-9.8%+31.6%
LOTTE Fine Chem 004000.KSSouth Korea$610M-45%+18%7%4.3×-20.1%+6.8%
Dainichiseika Color & Chemicals Mfg.Co 4116.TJapan$610M+23%+5%8%n/a1.8%-2.1%
MEC 4971.TJapan$582M-52%+31%32%14.7×16.1%+11.9%
Hangzhou Grascent 301688.SZChina$613Mn/a+12%n/an/a42.9%n/a
Miracll Chemicals 300848.SZChina$578M-46%+23%1%11.1×n/an/a
Hubei Hongyuan Pharmaceutical Technology 301246.SZChina$576M-57%+45%12%n/an/an/a
Cytech 301557.SZChina$619M-1%+13%7%n/an/an/a
DKS 4461.TJapan$573M+3%+31%15%9.5×7.2%+7.0%
Formosan Union Chemical 1709.TWTaiwan$619M+159%+14%41%n/a-17.9%+1.2%
Advanced Nano Products 121600.KSSouth Korea$572M-11%+33%12%47.1×27.9%+18.2%
Argus (Shanghai) Textile Chemicals 603790.SSChina$572M-30%+21%14%n/a10.6%+0.7%
Anhui Estone Materials Technology 688733.SSChina$622M-43%+52%-2%47.7×n/an/a
Tidewater Renewables LCFS.TOCanada$567M+71%+103%25%11.6×-12.6%+126.4%

Questions

Which companies are IOL Chemicals & Pharmaceuticals's closest peers?
The cockpit's peer set: Pan Asian Microvent Tech (Jiangsu) (688386.SS), Hangzhou Gaoxin Materials Technology (300478.SZ), Jiangsu Lopal Tech (2465.HK), Cybrid Technologies (603212.SS), Jiangsu Baichuan High-Tech New Materials (002455.SZ), Renxin New Material (301395.SZ), Zhejiang Jiaao Enprotech Stock (603822.SS), LOTTE Fine Chem (004000.KS).
Is IOL Chemicals & Pharmaceuticals expensive compared with its peers?
On forward p/e it trades at 22.3× against a peer median of 11.6×, 5th most expensive of 12 in its peer set. For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +3%, so the hurdle is +24 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has IOL Chemicals & Pharmaceuticals stock performed?
Over six months to 18 Nov 2026 the shares returned +72.3% against -30.4% for the median peer; over one year +92.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.